SLC5A3
Basic information
Region (hg38): 21:34073578-34106260
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC5A3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 22 | 22 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 22 | 1 | 0 |
Variants in SLC5A3
This is a list of pathogenic ClinVar variants found in the SLC5A3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
21-34073744-G-A | not specified | Uncertain significance (Dec 30, 2024) | ||
21-34095266-T-C | not specified | Uncertain significance (Feb 08, 2025) | ||
21-34095304-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
21-34095308-G-T | not specified | Uncertain significance (Feb 19, 2025) | ||
21-34095421-A-G | not specified | Uncertain significance (Oct 05, 2023) | ||
21-34095472-C-T | not specified | Uncertain significance (Dec 28, 2022) | ||
21-34095752-A-G | not specified | Uncertain significance (Aug 30, 2022) | ||
21-34095787-C-G | not specified | Uncertain significance (Dec 04, 2024) | ||
21-34095881-T-C | not specified | Uncertain significance (Jan 27, 2025) | ||
21-34095901-A-G | not specified | Uncertain significance (Jul 05, 2024) | ||
21-34096280-T-C | not specified | Uncertain significance (Jan 07, 2025) | ||
21-34096331-A-G | not specified | Uncertain significance (Jan 23, 2025) | ||
21-34096385-A-C | not specified | Uncertain significance (Dec 17, 2023) | ||
21-34096393-C-T | not specified | Uncertain significance (Jun 05, 2023) | ||
21-34096401-C-T | Likely benign (Aug 06, 2018) | |||
21-34096402-G-A | not specified | Uncertain significance (Feb 08, 2025) | ||
21-34096447-T-G | not specified | Uncertain significance (Sep 08, 2024) | ||
21-34096459-A-G | not specified | Uncertain significance (Aug 20, 2024) | ||
21-34096480-A-G | not specified | Uncertain significance (Oct 27, 2022) | ||
21-34096714-A-G | not specified | Uncertain significance (Feb 07, 2025) | ||
21-34096718-A-G | not specified | Uncertain significance (Sep 10, 2024) | ||
21-34096834-T-C | not specified | Uncertain significance (Dec 12, 2023) | ||
21-34096921-T-C | not specified | Uncertain significance (Oct 03, 2024) | ||
21-34096990-C-T | not specified | Uncertain significance (Jul 14, 2024) | ||
21-34097002-G-T | not specified | Uncertain significance (Feb 28, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC5A3 | protein_coding | protein_coding | ENST00000381151 | 1 | 32690 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.967 | 0.0326 | 125723 | 0 | 12 | 125735 | 0.0000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.76 | 247 | 403 | 0.613 | 0.0000211 | 4708 |
Missense in Polyphen | 31 | 144.62 | 0.21435 | 1637 | ||
Synonymous | -1.55 | 172 | 148 | 1.16 | 0.00000792 | 1472 |
Loss of Function | 3.66 | 2 | 19.4 | 0.103 | 9.78e-7 | 243 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000152 | 0.000152 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000528 | 0.0000528 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Prevents intracellular accumulation of high concentrations of myo-inositol (an osmolyte) that result in impairment of cellular function.;
- Pathway
- Nuclear Receptors Meta-Pathway;NRF2 pathway;Inositol transporters;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Transport of small molecules;Phosphatidylinositol phosphate metabolism;Fructose and mannose metabolism
(Consensus)
Recessive Scores
- pRec
- 0.381
Intolerance Scores
- loftool
- 0.0843
- rvis_EVS
- -0.67
- rvis_percentile_EVS
- 15.86
Haploinsufficiency Scores
- pHI
- 0.477
- hipred
- Y
- hipred_score
- 0.507
- ghis
- 0.401
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc5a3
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- inositol metabolic process;sodium ion transport;peripheral nervous system development;myo-inositol transport;regulation of respiratory gaseous exchange;transmembrane transport
- Cellular component
- plasma membrane;integral component of plasma membrane;integral component of membrane
- Molecular function
- myo-inositol:sodium symporter activity;glucose:sodium symporter activity